DNAe
dnae.com
Real Estate
Biotechnology
Health Care
As featured in
Claim pageClaim
Follow
Overview
News
Salaries
Products
People
Growth
Offices
Financials
Funding and backers
Latest round
Venture round
Feb 2021 · 5 yr ago
Grants
1
1 grant · CORDIS
Backers
2
imperialcollege, Excel Venture Management
The money's age
Long since its last round
67 months since the last round · not hiring
Momentum
0/100
no fresh signals
Last sign of life
this month
a posting or a news item
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Feb 24, 2021
Raised a round Venture round
Oct 1, 2020
Won a grant CORDIS
Feb 28, 2020
Raised a round Venture round
Jun 20, 2019
Raised a round Venture round
Jan 8, 2019
Raised a round Venture round
Jan 15, 2017
Raised a round Venture round
Jan 18, 2015
Acquisition DNAe Acquires nanoMR Inc. in a Strategic Move to Own Complete Workflow for Point-Of-Need NGS-Based Blood-To-Result Diagnostic · businesswire.com
Jan 15, 2015
Raised a round Venture round
Oct 25, 2013
Raised a round Venture round
Jun 10, 2013
Raised a round Venture round
Dec 17, 2012
Raised a round Venture round
Apr 4, 2012
Raised a round Venture round
Oct 18, 2011
Raised a round Venture round
Dec 23, 2010
Raised a round Venture round
Aug 13, 2010
Raised a round Venture round
Funding rounds
Registers and programsofficial lists and records that name the company
| Legal entity | DNAe Group Holdings Limited | its site |
Backed byfrom the funds' portfolios and accelerator catalogs
imperialcollege 
Excel Venture Management Investors in similar startupsfunds that back the companies most like this one
Similar startupsby what they do, their industry and backers
PathoQuest provides biosafety assays based on next-generation sequencing (NGS) for biologics quality testing. GMP biotesting for…
Bullseye Biosciences is a therapeutics discovery company revolutionizing drug development through robotics and evolution. Our platform…
A New Standard in Organ Transplantation. Accunea is pioneering the next generation of organ condition monitoring technology to ensure that…
Plantik develops resilient crops through next-generation plant engineering technologies.
The development infrastructure for the next generation of procedural devices.
Next Generation Financial Technology Platform for Creators and Brands.
News
DNAe Unveils Early Access Program for LiDia-SEQ: Hospital Teams Invited to Trial DNAe
DNAe, the Next-Generation Sequencing (NGS) company developing a transformative fully automated, sample-to-report diagnostics platform, today unveils a new Early Access Program, offering clinical partners an exclusive pre-launch preview of the results gene
Read more
Report
DNAe Unveils Early Access Program for LiDia-SEQ: Hospital Teams Invited to Trial DNAe
DNAe, the Next-Generation Sequencing (NGS) company developing a transformative fully automated, sample-to-report diagnostics platform, today unveils a new Early Access Program, offering clinical partners an exclusive pre-launch preview of the results gene
Read more
Report
AMP 2025: DNAe to unveil latest data from world
DNAe, the Next-Generation Sequencing (NGS) company developing a transformative fully automated, sample-to-report diagnostics platform, today announces that it will be presenting brand-new data on novel testing applications in oncology monitoring, bloodstr
Read more
Report
AMP 2025: DNAe to unveil latest data from world's first NGS-based, fully automated sample-to-result diagnostic platform
Poster presentations will preview new data from breakthrough bloodstream infection detection and oncology tests running on first-of-its-kind Lilia-SEQ platform LONDON
Read more
Report
Hello world!
Welcome to WordPress. This is your first post. Edit or delete it, then start writing!
Read more
Report
DNAe announces pipeline of genomic-based tests for everyday workflow of physicians and hospitals
DNAe, the inventor of next generation semiconductor DNA sequencing technology and developer of a new, game-changing test for bloodstream infections, announces that its CBO, Nick McCooke presented an update on its first product, the LiDia bloodstream infec
Read more
Report
DNAe Secures £25 Million ($38 Million) Bank Facility to Fund Development of Pioneering Point-of-Need IVD for Serious Blood Infections
Read more
Report
DNAe's nanoMR Acquisition Geared to Develop Point-of-Need Blood Test
Integration of the two organizations is effective immediately, creating an 80+ team with facilities in the U.K. and the U.S. that will operate under the DNAe brand.
Read more
Report
Show more news
Financials
Latest round
Venture - Series Unknown
Funding rounds
14
Funding rounds
| Round | Announced | Amount | |
|---|---|---|---|
| Venture - Series Unknown | 2021 | — | Details |
| Grant | 2020 | — | Details |
| Venture - Series Unknown | 2020 | — | Details |
| Venture - Series Unknown | 2019 | — | Details |
| Venture - Series Unknown | 2019 | — | Details |
| Venture - Series Unknown | 2017 | — | Details |
| Venture - Series Unknown | 2015 | — | Details |
| Venture - Series Unknown | 2013 | — | Details |
| Venture - Series Unknown | 2013 | — | Details |
| Venture - Series Unknown | 2012 | — | Details |
| Venture - Series Unknown | 2012 | — | Details |
| Venture - Series Unknown | 2011 | — | Details |
| Venture - Series Unknown | 2010 | — | Details |
| Venture - Series Unknown | 2010 | — | Details |